We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-11.81%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73M
AUM Growth
-$5.17B
(-100%)
Cap. Flow
-$776M
Cap. Flow
% of AUM
-13,535.32%
Top 10 Holdings %
Top 10 Hldgs %
49.82%
Holding
217
New
75
Increased
44
Reduced
24
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$93.9M |
| 2 |
lululemon athletica
LULU
|
+$73.2M |
| 3 |
Dollar General
DG
|
+$71.9M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$67.6M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$62.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$105M |
| 2 |
Biogen
BIIB
|
+$68.7M |
| 3 |
Target
TGT
|
+$68.3M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$62.1M |
| 5 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.4% |
| 2 | Consumer Staples | 8.91% |
| 3 | Consumer Discretionary | 7.35% |
| 4 | Technology | 4.07% |
| 5 | Communication Services | 1.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Booking.com
BKNG
$149B
| $5.6K | 0.1% |
+80,000
| New | +$6.83M |
|
102
HubSpot
HUBS
$12.2B
| $5.41K | 0.09% |
+18,000
| New | +$6.57M |
|
103
Viatris
VTRS
$20.4B
| $5.24K | 0.09% |
500,000
-5,300,000
| -91% | -$58.1M |
|
104
Electronic Arts
EA
$53B
| $4.87K | 0.08% |
+40,000
| New | +$5.1M |
|
105
Twilio
TWLO
$30B
| $4.69K | 0.08% |
+56,000
| New | +$6.26M |
|
106
Puma Biotechnology
PBYI
$404M
| $4.28K | 0.07% |
+1,500,000
| New | +$3.73M |
|
|
HYPD
107
Hyperion DeFi Inc
HYPD
$40M
| $3.77K | 0.07% |
24,178
-4,530
| -16% | -$828K |
|
|
SLAI
108
DELISTED
SOLAI Ltd ADS
SLAI
| $3.19K | 0.06% |
+73,525
| New | +$9.19M |
|
|
VGFC
109
DELISTED
The Very Good Food Company
VGFC
| $3.09K | 0.05% |
+13,100,000
| New | +$3.7M |
|
|
NOVN
110
DELISTED
Novan, Inc. Common Stock
NOVN
| $3.05K | 0.05% |
+1,307,103
| New | +$3.61M |
|
|
BIOL
111
DELISTED
Biolase, Inc.
BIOL
| $2.96K | 0.05% |
+6,461
| New | +$3.55M |
|
|
EZRA
112
Reliance Global Group
EZRA
$1.49M
| $2.82K | 0.05% |
+131
| New | +$3.63M |
|
113
Verastem
VSTM
$510M
| $2.32K | 0.04% |
166,667
| – | – |
|
114
Eterna Therapeutics
ERNA
$3.83M
| $2.25K | 0.04% |
579
-154
| -21% | -$1.11M |
|
|
STKH
115
Steakholder Foods
STKH
$1.42M
| $1.95K | 0.03% |
+490
| New | +$2.45M |
|
116
Greenlane Holdings
GNLN
$1.22M
| $1.86K | 0.03% |
+1
| New | +$4.45M |
|
|
ELYS
117
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
| $1.66K | 0.03% |
+2,258,484
| New | +$3.05M |
|
118
Edesa Biotech
EDSA
$49.2M
| $1.65K | 0.03% |
146,182
-61,902
| -30% | -$912K |
|
119
VerifyMe
VRME
$9.38M
| $1.54K | 0.03% |
+786,896
| New | +$2.13M |
|
|
IMBI
120
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $1.46K | 0.03% |
+1,208,275
| New | +$3.45M |
|
121
Biofrontera
BFRI
$15M
| $1.42K | 0.02% |
+38,182
| New | +$2.32M |
|
|
ARAV
122
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.3K | 0.02% |
1,316,129
+381,154
| +41% | +$503K |
|
123
Trevi Therapeutics
TRVI
$2.59B
| $1.17K | 0.02% |
+416,000
| New | +$1.02M |
|
124
ABVC BioPharma
ABVC
$26.3M
| $1.16K | 0.02% |
+109,275
| New | +$2.21M |
|
125
GeoVax Labs
GOVX
$3.55M
| $1.13K | 0.02% |
3,623
+2,463
| +212% | +$1.09M |
|
Similar funds
CRC
RMDI
F
DCP
EW
O
PA
DSC
Armistice Capital's Q2 2022 Portfolio in Review
As of Q2 2022, Armistice Capital held 217 positions worth $5.73M, down 100% from $5.17B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Armistice Capital withdrew a net $776M in Q2 2022, closing 41 positions and reducing 24 holdings. Its most notable exit was Home Depot, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Armistice Capital opened a new position in O'Reilly Automotive worth $92K.
- Armistice Capital's largest Q2 2022 buy was O'Reilly Automotive: 2,183,715 shares worth $92K.
- Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2022, an estimated $67.6M increase.
- Armistice Capital's biggest Q2 2022 reduction was Biogen, cutting an estimated $68.7M.
- Armistice Capital fully exited Home Depot in Q2 2022, selling an estimated $105M.
- Armistice Capital's ten largest holdings make up 50% of its $5.73M portfolio in Q2 2022.
- Armistice Capital opened 75 new positions and closed 41 in Q2 2022.
- Armistice Capital's portfolio value fell 100% quarter-over-quarter to $5.73M.
Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.